Medical cannabis: market revenue Uruguay 2016-2029

The revenue of the medical cannabis segment of the cannabis market in Uruguay was forecast to continuously increase between 2024 and 2029 by in total nine million U.S. dollars (+12.79 percent). After the thirteenth consecutive increasing year, the indicator is estimated to reach 79.36 million U.S. dollars and therefore a new peak in 2029. Notably, the revenue of the medical cannabis segment of the cannabis market was continuously increasing over the past years.

Revenue of the medical cannabis market in Uruguay from 2016 to 2029, by segment (in million U.S. dollars)

Characteristic	Revenue in million U.S. dollars
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

More information

Supplementary notes

Data provided by Statista Market Insights are estimates.

Definition:
The medical cannabis market encompasses products derived from the cannabis plant specifically used for medical purposes. These products may include dried flowers, oils, tinctures, capsules, and topicals. Depending on the regulations in each country or state, these products are available through medical dispensaries, pharmacies, and/or online platforms. They may be consumed in various ways such as smoking, vaporizing, ingesting, or applying topically.

Structure:
The medical cannabis market involves cannabinoid-based medicine without marketing authorization. These unlicensed medicines are supplied through health systems, prescribed by doctors, or used as Active pharmaceutical ingredients (API). The API is manipulated and/or compounded by a magistral pharmacy to prepare a cannabinoid-based medicine without marketing authorization. The medical cannabis market includes various forms of cannabis such as flowers, oils, capsules, and topicals.

Additional information:
Market values represent the revenues generated by retail prices paid to vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by patients (B2C), healthcare facilities (B2B), and governments (B2G).

Citation formats